Brief: Indaptus Therapeutics Announces Clinical Supply Agreement With Beigene To Evaluate Novel Cancer Treatment Combinations

Indaptus Therapeutics

22/10/2024 13:40

Oct 22 (Reuters) - Indaptus Therapeutics Inc  INDP.O :
    * INDAPTUS THERAPEUTICS ANNOUNCES CLINICAL SUPPLY AGREEMENT
WITH
BEIGENE TO EVALUATE NOVEL CANCER TREATMENT COMBINATIONS
    * INDAPTUS THERAPEUTICS INC - INDUSTRY FIRST CLINICAL TRIAL
COMBINING TISLELIZUMAB AND DECOY20 EXPECTED  TO START IN 2025

Source text for Eikon:  ID:nGNX5tlbXt 
Further company coverage:  INDP.O 

 ((Reuters.Briefs@thomsonreuters.com))